Bristol Myers Squibb (BMY) is a publicly traded Healthcare sector company. As of July 4, 2026, BMY trades at $58.13 with a market cap of $118.71B and a P/E ratio of 16.75. BMY moved +2.80% today. Year to date, BMY is +7.23%; over the trailing twelve months it is +22.04%. Its 52-week range spans $42.52 to $63.33. Analyst consensus is buy with an average price target of $63.13. Rallies surfaces BMY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for BMY shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $58.13 |
| Market Cap | $118.71B |
| P/E Ratio | 16.75 |
| EPS | $3.47 |
| Dividend Yield | 0.63% |
| 52-Week High | $63.33 |
| 52-Week Low | $42.52 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $48.19B |
| Net Income | $7.05B |
| Gross Margin | 71.08% |
20 analysts cover BMY: 0 strong buy, 7 buy, 12 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $63.13.